Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trial. Local targets link to admitted publications; unresolved targets remain external evidence.
Oxaliplatin-containing preoperative therapy in locally advanced rectal cancer: local response, toxicity and long-term outcome
10.1016/j.clon.2016.01.014 · 2016 · External reference
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
10.1200/jco.2005.02.9793 · 2006 · External reference
Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging
10.1002/bjs.4034 · 2003 · External reference
Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison
10.1148/radiol.2272011747 · 2003 · External reference
Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer
10.1200/jco.2004.05.188 · 2004 · External reference
Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
10.1200/jco.2007.15.3858 · 2008 · External reference
Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy
10.1002/cncr.10327 · 2002 · External reference
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
10.1016/s1470-2045(20)30555-6 · 2021 · External reference
Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the chinese FOWARC trial
10.1200/jco.18.02309 · 2019 · External reference
Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)
10.1200/jco.21.01667 · 2022 · External reference
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO/AIO-12 randomized clinical trial
10.1001/jamaoncol.2021.5445 · 2022 · External reference
Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy
10.1200/jco.22.00032 · 2022 · External reference
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
10.1016/s1470-2045(21)00079-6 · 2021 · External reference
Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial
10.1200/jco.2016.66.6198 · 2016 · External reference
Neoadjuvant modified infusional fluorouracil, leucovorin, and oxaliplatin with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: updated results of the FOWARC study after a median follow-up of 10 years
10.1200/jco-24-01676 · 2025 · External reference
Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial
10.1016/j.ejca.2023.02.027 · 2023 · External reference
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial
10.1016/j.annonc.2024.06.019 · 2024 · External reference
Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial
10.1200/jco.23.01208 · 2024 · External reference
Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer: 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison
10.1016/j.esmoop.2025.104483 · 2025 · External reference
Quality of life and functional outcomes in patients with locally advanced rectal cancer receiving total neoadjuvant therapy versus concurrent chemoradiation therapy: an analysis of the STELLAR trial
10.1016/j.ijrobp.2024.12.035 · 2025 · External reference
Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study
10.1148/radiol.2431051825 · 2007 · External reference
Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, european study
10.1097/sla.0b013e31820b8d52 · 2011 · External reference
